These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Association between Antibody Responses to Epstein-Barr Virus Glycoproteins, Neutralization of Infectivity, and the Risk of Nasopharyngeal Carcinoma. Zhu QY, Kong XW, Sun C, Xie SH, Hildesheim A, Cao SM, Zeng MS. mSphere; 2020 Dec 02; 5(6):. PubMed ID: 33268566 [Abstract] [Full Text] [Related]
6. Expression of EBV antibody EA-IgA, Rta-IgG and VCA-IgA and SA in serum and the implication of combined assay in nasopharyngeal carcinoma diagnosis. Xia C, Zhu K, Zheng G. Int J Clin Exp Pathol; 2015 Dec 02; 8(12):16104-10. PubMed ID: 26884888 [Abstract] [Full Text] [Related]
8. Diagnostic significance of combined detection of Epstein-Barr virus antibodies, VCA/IgA, EA/IgA, Rta/IgG and EBNA1/IgA for nasopharyngeal carcinoma. Cai YL, Li J, Lu AY, Zheng YM, Zhong WM, Wang W, Gao JQ, Zeng H, Cheng JR, Tang MZ. Asian Pac J Cancer Prev; 2014 Dec 02; 15(5):2001-6. PubMed ID: 24716925 [Abstract] [Full Text] [Related]
9. Molecular diversity of Epstein-Barr virus IgG and IgA antibody responses in nasopharyngeal carcinoma: a comparison of Indonesian, Chinese, and European subjects. Fachiroh J, Schouten T, Hariwiyanto B, Paramita DK, Harijadi A, Haryana SM, Ng MH, Middeldorp JM. J Infect Dis; 2004 Jul 01; 190(1):53-62. PubMed ID: 15195243 [Abstract] [Full Text] [Related]
10. Application of logistic regression in combination with multiple diagnostic tests for auxiliary diagnosis of nasopharyngeal carcinoma. Jiang SQ, Liu Q. Ai Zheng; 2009 Feb 01; 28(2):177-80. PubMed ID: 19550133 [Abstract] [Full Text] [Related]
16. IgA antibodies against the Epstein-Barr nuclear antigen1 as a valuable biomarker for the diagnosis of nasopharyngeal carcinoma in Tunisian patients. Ayadi W, Karray-Hakim H, Feki L, Khabir A, Boudawara T, Ghorbel A, Daoud J, Frikha M, Hammami A. J Med Virol; 2009 Aug 01; 81(8):1412-21. PubMed ID: 19551836 [Abstract] [Full Text] [Related]
18. Analyses of the prognostic significance of the Epstein-Barr virus transactivator ZEBRA protein and diagnostic value of its two synthetic peptides in nasopharyngeal carcinoma. Dardari R, Menezes J, Drouet E, Joab I, Benider A, Bakkali H, Kanouni L, Jouhadi H, Benjaafar N, El Gueddari B, Hassar M, Khyatti M. J Clin Virol; 2008 Feb 01; 41(2):96-103. PubMed ID: 18024156 [Abstract] [Full Text] [Related]
20. Evaluation of a semi-quantitative ELISA for IgA antibody against Epstein-Barr virus capsid antigen in the serological diagnosis of nasopharyngeal carcinoma. Chen H, Chi P, Wang W, Li L, Luo Y, Fu J, Zhang L, Liu W. Int J Infect Dis; 2014 Aug 01; 25():110-5. PubMed ID: 24878579 [Abstract] [Full Text] [Related] Page: [Next] [New Search]